BN Business News
Add your company to Business Communicator →

Business · 04/11/20261 min read

Opinion/decision on a plan of investigation for paediatric use (PIP): Zebinix, eslicarbazepine acetate, type of decision: PM: Decision on the application for modification of an agreed PIP, therapeutic area: Nervous system disorders;Neurology, PIP number: EMA/PE/0000248063

Summary

Opinion/decision on a plan of investigation for paediatrics (PIP): Zebinix, eslicarbazepine acetate, type of decision: PM: decision on the application for modification of an agreed PIP, therapeutic area: nervous system...

Original source language: EMA — Paediatric Investigation PlansOpen original release →

Explore insights

Business insights →